Hepatocellular carcinoma in Germany: A retrospective epidemiological study from a low-endemic area

Liver

Volumn 20, Issue 4, 2000, Pages 312-318

  Kubicka, Stefan ^a   Rudolph, Karl Lenhard ^a   Hanke, Martina ^a   Tietze, Maja Katrin ^a   Tillmann, Hans Ludger ^a   Trautwein, Christian ^a   Manns, Michael ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Epidemiology; Hepatitis virus; Hepatocellular carcinoma; Risk factor

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; ECHOGRAPHY; ENDEMIC DISEASE; FEMALE; GERMANY; HEPATITIS B; HEPATITIS C; HEPATITIS VIRUS; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; GERMANY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033915901     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2000.020004312.x     Document Type: Article

References (47)

1. Hepatocellular carcinoma. A worldwide problem and the major risk factors
2. Cancer incidence in five continents
3. Epidemiology of hepatocellular carcinoma
4. Risk factors for hepatocellular carcinoma among patients with chronic liver disease
5. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: A multicenter Italian study
6. Hepatocellular carcinoma complicating autoimmune hepatitis: Role of hepatitis C virus
7. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis
8. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis
9. Survival and cause of death in cirrhotic and noncirrhotic patients with primary hemochromatosis
10. Long term survival analysis in hereditary hemochromatosis
11. Risk of cirrhosis and primary liver cancer in alphal-antitrypsin deficiency
12. Hepatocellular carcinoma in Wilson's disease. Case report and review of the literature
13. Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation
14. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 2707 men in Taiwan
15. Clinicopathologic features of hepatocellular carcinoma in young patients
16. HCV- associated hepatocellular carcinoma without cirrhosis
17. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan
18. Clinicopathological features of hepatocellular carcinoma - Comparison of hepatitis B seropositive and seronegative patients
19. Changing incidence of hepatocellular carcinoma in Japan
20. Increase in primary liver cancer in the UK, 1979-94
21. Trends in primary liver cancer
22. Rising incidence of hepatocellular carcinoma in the United States
23. HBV-associated liver cancer without cirrhosis
24. Current pathogenic and molecular concepts in viral liver carcinogenesis
25. Hepatitis B virus related hepatocellular carcinoma: Chronicity of infection - The opening to different pathways of malignant transformation?
26. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma
27. Transactivation of cellular gene expression by hepatitis B viral proteins: A possible molecular mechanism of hepatocarcinogenesis
28. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
29. Hepatis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene
30. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
31. Transcriptional regulation of cellular and viral promotors by the hepatitis C virus core protein
32. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells
33. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki prefecture, Japan
34. Characteristics of hepatocellular carcinoma in Italy
35. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: Results of a European concerted action
36. Hepatitis C virus and hepatocellular carcinoma
37. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children.
38. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection
39. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: Tumor multicentricity in cirhotic liver with hepatitis C
40. The diagnosis of small hepatocellular carcinomas: Efficacy of various imaging procedures in 100 patients
41. Diagnosis and staging of hepatocellular carcinoma
42. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-Fetoprotein
43. Prospective study of a-Fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma
44. Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study
45. Screening for hepatocellular carcinoma in patients with child's A cirrhosis: An 8-year prospective study by ultrasound and alphafetoprotein
46. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma group d'Etude et de traitement du carcinome hepatocellulaire.